Retatrutide — lab test, July 2026
COA KVR-2026-E2C16A matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Q7ROUCITest results
About this test
Label 30 mg · Lab measured 30.11 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 7.5 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-E2C16A |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 26 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Kovera Labs on July 10, 2026. Reported purity: 99.67%. Net content: 30.11 mg against 30 mg labeled (100% of label). Endotoxins: PASS (≤0.5 EU/mL). Heavy metals: Arsenic, Cadmium, Lead, Mercury — all Negative. Batch RT30-072026-001. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion